
Soni Smith MD
@sonismithmd
Lymphoma doctor, University of Chicago, love cooking and family. Views and opinions my own.
ID: 1134857587348967425
01-06-2019 16:21:48
864 Tweet
2,2K Followers
865 Following

Soni Smith MD Fully agree!!! An adequate specimen at the very begining gives a better service to our patients!

Hear from and connect w other #WomenInOncology in a new series, Navigating Mid-Career Success ā don't miss the first session on Tues. 10/24! Register: brnw.ch/21wDBQQ Hematology & Oncology Women Physicians GroupāHOWPG Ishwaria Subbiah, MD MS FASCO Suzanne Cole, MD, FACP, FASCO Soni Smith MD Ariela Marshall MD Ashley Love Sumrall, MD, FACP, FASCO Nathalie Mckenzie, MD MSPH


Congrats to Greg Roloff!




Kicking off the MSKCC Lymphoma Symposium with a wonderful comprehensive review of DLBCL by Laurie Sehn #msklymphomacme #msksme


UChicago Annual Practice Updates in Hematology and Oncology - UChicagoCancerCenter University of Chicago Hematology/Oncology #ASCO2024 #Cancer #OncoDaily #Oncology #UChicagoCancerCenter oncodaily.com/105529.html

We are proud to announce that UChicago Medicine Comprehensive Cancer Center has been ranked #1 in Illinois and #12 in the nation in the latest U.S. News & World Report's Best Hospitals. UChicagoCancerCenter is committed to providing highest quality care to cancer patients.

I am proud that UChicagoCancerCenter is nationally ranked #12 and #1 in Illinois in the latest U.S. News & World Report #BestHospitals for Cancer. This reflects our exceptional patient care, groundbreaking research & innovative treatments. Kunle Odunsi, MD #NothingWillStopUs ow.ly/gMti50SFgCN

Great start to the inaugural University of Chicago Practice Updates in Hematology/Oncology with post-ASCO practice changing data!!! University of Chicago Hematology/Oncology University of Chicago Hem/Onc Fellows #cancer


#WiLingWednesdays #IndolentLymphoma #webinar Thank you Jessica Okosun & Carla Casulo, MD - excellent presentations and discussion! šwatch video recording us06web.zoom.us/rec/share/_cED⦠With thanks to Gilead Sciences #IFLI Eli Lilly and Company Lymphoma Australia #lymphoma #lymsm #WomeninLymphoma


āļø #IndolentLymphoma free educational webinar š Wednesday, Nov 6 ā° 4pm CET/3pm GMT/10am EST 𩺠clementine sarkozy cottereau anne segolene šRegister here us06web.zoom.us/webinar/regist⦠With thanks to Gilead Sciences #IFLI Eli Lilly and Company Lymphoma Australia



š©ŗāļøPlease join WiL's global community for a compelling #debate on High Risk relapsed FL treatment options with #KimLintonš¬š§& Astrid Pavlovsky š¦š· šREGISTER us06web.zoom.us/webinar/regist⦠With thanks to Gilead Sciences #IFLI Eli Lilly and Company Lymphoma Australia #lymsm #lymphoma #IndolentLymphoma



the practice changing STARGLO phase 3 trial demonstrating OS superiority for glofitamab-GemOx over R-GemOx in r/r DLBCL published today in The Lancet erudite commentary from Anna Sureda Astrid Pavlovsky #lymSMfree access via this link: authors.elsevier.com/c/1k60aV-4XOujG


šPlease join our free educational #CareerDevelopment webinar next Wed Nov 20 with Laurence Hollobon & panel of emerging women in lymphoma āļø šRegister us06web.zoom.us/webinar/regist⦠With thanks to Gilead Sciences #IFLI Eli Lilly and Company Lymphoma Australia #lymphoma #lymsm #womeninmedicine


š§Our DEPEND trial is out! Neoadjuvant nivo/chemo followed by response-stratified CRT in HPV-negative stage IVa/b HNSCC. UChicagoCancerCenter University of Chicago Hematology/Oncology Aditya Juloori Pearson Lab Nishant Agrawal Evgeny Izumchenko Everett Vokes jamanetwork.com/journals/jamaoā¦

Using Cure Models for Trial Analysis and Design: now in print by my colleague Michael LeBlanc SWOG Cancer Research Network Journal of Clinical Oncology | ascopubs.org/doi/full/10.12ā¦